The Extraordinary General Meeting No. 1/2014 Sikarin Public Company

The Extraordinary General Meeting No. 1/2014

Sikarin Public Company Limited

Thursday, September 11, 2014 at 9.00 a.m.

The Meeting Room, 2nd Floor Sikarin Hospital, No. 4/29, Moo 10 Srinakarin Road, Bang Na Sub-district, Bang Na District, Bangkok.

No. Sor.Kor. 0489/2014

August 18, 2014.

Shareholders, Sikarin Public Company Limited

Enclosure: 1. A copy of the minutes of the 36 Ordinary General Shareholders’ Meeting. 2. Form F53-4. 3. Information of Company, 4. Letter of Proxy, Form A, B, C,. 5. Criteria, methods and regulations on those concerning the Shareholders’ Meeting. 6. Map of the meeting venue, Sikarin Hospital, Building 1.

Dear Shareholders,

The Board of Directors of Sikarin Public Co., Ltd. has resolved to call the Extraordinary General Meeting of Shareholders No. 1/2014 on Thursday, September 11, 2014 at 9.00 o’clock at the Meeting Room 2nd Floor, Building 1, Sikarin Hospital, No. 4/29 Moo 10, Srinakarin Road, Bang Na Sub-district, Bang Na District, Bangkok. The agendas of the meeting are as follows:

Agenda 1. Comments from the Chairman,

Agenda 2. To consider and approve the Minutes of the 36 Ordinary General Shareholders’ Meeting, Facts and reasons: The 36 Ordinary General Shareholders’ Meeting was held on Wednesday, April 23, 2014, shown in the minutes of the meeting sent to shareholders along with the notification of this meeting. Board’s opinions: The Board feels appropriate to put forward the minutes of the 36 Ordinary General Shareholders’ Meeting to shareholders for their approval.

Agenda 3. To considerto change the condition of allotment of new shares, Facts and reasons: According to a resolution in the 2/2003 Extraordinary General Meeting of shareholders on December 11, 2003 to allocate 40,000,000 common shares as capital increase to cope with execution of the share warrants, due on August 30, 2008, Sikarin can subsequently reallocate those shares. Board’s opinions: The Board feels appropriate to propose to shareholders to consider approving the change of the common share allocation for capital increase to the following:

1. Specifying the purpose of utilizing proceeds 1.1 Allotment of new shares 20,000,000 shares with a par value of THB 6.50 to existing shareholders. Rights offering at the ratio of 5 existing ordinary shares to 1 new share at the

2 offering price of THB 15. The Record Date to determine the shareholders who are entitled to subscribe the newly issued shares on October 1, 2014. Also, October 2, 2014 shall be the book closing date on which the shareholders list as specified in section 225 of the Securities and Exchange Act shall be complied. The period of subscription the capital increase from November 3, 2014 until November 7, 2014. 1.2 In case any newly issued ordinary shares remaining unsubscribed from the right offering, Board of director or person who has been authorized by the board of director must allocate newly issued ordinary shares remaining by excess right to existing shareholder’s need or an oversubscribed request by the same ratio proportion until newly issued ordinary share will be complete allocated. Allotment need to focus on newly issued ordinary share remaining and oversubscribed request. There for, the board of director or an authorized person by the board of director has right to settle newly issued policy and conditions. 1.3 In case a share fraction, a shareholder allocated with a fraction of a share or less than one share, that fraction shall be deleted.

2. General mandate 2.1 Allotment of 15,000,000 common shares for capital increase at the par value of THB 6.50 each, and offered to sell to original shareholders as Right Offering, and authorized the Board to offer to sell those shares for capital increase at one time or several times as well as to set the selling prices, date and time of offer, details and conditions related to the share allocation. The share allocation shall be completed by the date the Company will hold the following Annual General Meeting or by the date the law requires the Company to hold the following Annual General Meeting. The Board shall also be authorized to negotiate and sign on documents and contracts related to the share allocation, sign on applications for permits or documents necessary and related to the share allocation, as well as to deal with or apply for documents or evidence from a government agency or related organization, and get the common shares for capital increase registered in the Stock Market, and have authority to handle other things, necessary and appropriate to the share allocation. 2.2 Allotmentof 5,000,000 common shares for capital increase at the par value of THB 6.50 each, and offered to sell some or all those shares at one time or several times to specific investors and/or institutional investors as private placement in accordance with the Capital Market Supervisory Board’s Notification No. TJ. 28/2551 on applying and granting permission to offer to sell new shares, dated December 15, 2008 at the price not less than 90 percent of the market price. The “market price” shall be calculated from average prices with weights of share trading in the stock market for at least 7 and not more than 15 successive working days before the date the Board of Directors or Executive Board has resolved to allocate and offer to sell shares to investors.

The Board of Directors or a person assigned by the Board of Directors shall have authority to allocate those common shares for capital increase, and schedule the date to offer to sell and set other conditions in relation to the share allocation to investors according to the criteria, specified by the law.

Agenda 4. Others (if any) Shareholders register book for the right to receive for 1/2014 Extraordinary General Meeting of shareholders shall be recorded on August 14, 2014. Also, August 15, 2014 shall be the book closing date on which the shareholders list as specified in section 225 of the Securities and Exchange Act shall be complied.

We look forward to seeing you in the meeting.

By the Board of Director’s resolution

(Mr. Suriyan Kojonroj) Company Secretary

Sikarin Public Company Limited Minutes of the Annual General Meeting of Shareholders No. 36 ……………………………………………………….

The Annual General Meeting was held on Wednesday, April 23, 2014, at the Meeting Room, 2nd Floor, Sikarin Hospital, Building 1, No. 4/29, Moo 10, Srinakarin Road, Bang Na Sub-district, Bang Na District, Bangkok.

The Meeting was attended by 63 shareholders and 153 proxies, totaling 216, holding 74,060,512 shares out of the Company’s total 100,000,000 shares distributed, representing 74.06 percent, exceeding one third of the total number of shares with voting rights, and thus making quorum for the Meeting according to the Company’s Articles of Association.

The Meeting commenced at 9.19 a.m. with Prof. Dr. Wissanu Kreangam, Chairman, chaired the meeting. The Chairman declared the meeting open and the meeting proceeded with the following agendas:

Agenda 1: Information from the Chairman 1.1 The Chairman introduced Chairman of the Advisory Board, Directors, management and related personnel in the meeting to shareholders. They’re as follows:

Directors attending the meeting 1. Prof. Dr. Wissanu Kreangam, Chairman, Board of Directors, 2. Gen. Viroj Sangsnit, Chairman, Advisory Board, 3. Pol. Lt. Gen. JaraxSangtaweep, Vice Chairman & Executive Chairman, 4. Mr. Sakchai Tanaboonchai, Vice Chairman & Compensation Committee Chairman, 5. Mr. Sanya Sarayudh, Vice Chairman & Executive Director, 6. Dr. Atirat Charoonsri, Managing Director, 7. Mr. Krajang Jaruprukphan, Director, 8. Mr. Jarun Wiwatjesadawut, Director & Recruitment Committee Member, 9. Mr. Seni Jittakasem, Director & Compensation Committee Member, 10. Mr. Kitipan Sasanavin, Director, Recruitment Committee Chairman, 11. Mr. Pramuanchai Taweesedt, Director & Audit Committee Chairman, 12. Mr. Amornrit Kaosaiyanon, Director & Audit Committee Member, 13. Mr. Raj Tanta-Nanta, Director & Compensation Committee Member, 14. Mr. Sucheep Boonveera, Director & Executive Director, 15. Mr. Senee Krajangsri, Director & Executive Director, 16. Mr. Kasidit Ajanant, Director & Audit Committee Member, 17. Gen. Ekachai Chansri, Advisor to the Board.

Management attending the meeting 1. Mr. Suriyan Kojonroj, Company Secretary and Chief Operation Officer, 2. Mr. Surasak Suttamas, Chief Executive Officer, 3. Dr. Thongchai Chatyingmongkol, Director (Medical Affairs), Sikarin Hospital, 4. Miss Penruedee Jitlekha, Director (Accounting and Finance), 5. Mr. Pongsak Khanich, Director (Legal Affairs), 6. Mrs. Parinda Vongsakul, Director, Office of the Secretary.

Auditors attending the meeting 1. Mr. Pojana Asavasantichai, 2. Miss Pojanarat Siripipat.

The Chairman informed the assembly that Sikarin had set up an Investor Relations Center, to handle this meeting under the Office of the Secretary, having Mrs. ParindaVongsakul as Director of that Office. It would serve as an additional channel to communicate with shareholders in terms of suggestions, objections or AGM procedures. Shareholders might be called to remind of the meeting.

In addition, Sikarin has applied E-Register and E-Voting of the Securities Depository Center, Stock Exchange of Thailand for the registration and voting in the meeting and invited officers of the Securities Depository Center to control and handle the computer program. In order for shareholders to understand voting procedures, the Company Secretary (Mr. SuriyanKojonroj) will elaborate how to cast and count votes at each agenda.

The Company Secretary informed the assembly that before the Annual General Meeting, Sikarin gave a chance to shareholders to propose an issue to table as an agenda and/or nominate a candidate to run as a Director during the period December 3 to 31, 2013 but no one proposed any issues or nominated anyone for directorship. Sikarin has published the notification for the meeting in its website and notified the Stock Exchange of Thailand since March 27, 2014. In addition, Sikarin has prepared the Company’s Articles of Association in Thai and English, notification for the meeting in Thai and English as well as Memorandum of Association in Thai and English for every shareholder. If anyone wants to have a copy, please ask from the staff outside the meeting room.

Mr. SuriyanKojonroj (Company Secretary) informed the assembly that the meeting would proceed according to the agendas distributed in advance to the shareholders. To cast votes at each agenda, an officer would collect a ballot from each shareholder and hand it over to the officer of the Securities Depository Center, who would record and process the votes. If anyone wished to change the agenda order, he/she could make that proposal. The agenda order would be changed if the assembly agreed with at least two thirds supporting the proposal

1.2 The Chairman informed the assembly that to ensure transparency in the meeting, the Chairman asked a few volunteers among shareholders to witness vote counting. The 3 volunteers were:

(1) Miss Kanjana Kokmani, (2) Miss Petchara Jitlertfa, (3) Mr. Ekarat Pranitipong.

During the course of the meeting, if anyone wished to ask a question or ask for further clarification at an agenda, please identify themselves first so that their names would be correctly recorded in the minutes. In case the assembly cast votes on an agenda and it would take time to count the votes, the Chairman would proceed to another agenda. And once vote counting was done, the vote results would be immediately announced to the assembly.

The assembly acknowledged the Chairman’s presentations.

Agenda 2: To consider and approve the Minutes of the Annual General Meeting of Shareholders, No. 35

The Chairman presented the Minutes of the 2013 Annual General Meeting of shareholders, held on Tuesday, April 23, 2013 for the assembly’s approval. Details of the minutes had been sent to shareholders together with the notification of this Meeting and publicized in the website. The Chairman then asked the assembly approve the minutes.

As nobody made other suggestions or asked for correction of the minutes, the Chairman asked the assembly to approve the minutes of the AnnualGeneral Meeting of shareholders, No. 35, held on Tuesday, April 23, 2013.

The assembly unanimously approved minutes of the AnnualGeneral Meeting of shareholders, No. 35, held on Tuesday, April 23, 2013 with the following votes:

Shareholders No. of Shares (Votes) Percentage Approve, 74,115,612 100.0000 Disapprove, 0 0.0000 Abstain, 0 0.0000 Total 219 voters 74,115,612 100.0000

Agenda 3: To consider and acknowledge the Company’s Operating Results for the year 2013

The Chairman asked the Managing Director to present Sikarin’s Operating Results in 2013 to shareholders and informed the assembly that no votes would be cast on this agenda but the presentation would be made for shareholders’ information. However, shareholders could ask questions or offer suggestions.

The Managing Director reported the Company’s Operating Results for 2013 to the assembly that Sikarin Hospital earned a total revenue of Bt1.706 billion and registered expenses of Bt1.519 billion, making a net profit of Bt148.67 million or a profit per share of

Bt1.50. compared with 2012, the net profit was Bt119.83 million or a profit per share of Bt1.27. The profit in 2013 rose by 24.07%.

In 2013, the revenue from medical services was Bt1.65 billion, from food Bt34.96 million and other revenues Bt20.34 million, making the total revenue of Bt1.705 billion. Cost of sales totaled Bt1.135 billion, cost of food and drink sales Bt20.04 million and administration expenses of Bt341.17 million. The income before tax and interest was Bt209.76 million. The total interest was Bt23.40 million and tax Bt37.68 million. The net profit was therefore Bt148.67 million. The EBITDA Margin was 19.81 percent, net profit 8.72 percent and return per share Bt1.50. The hospital’s assets as of the end of 2013 stood at Bt2.025 billion, liabilities Bt678.31 million and shareholders’ equity Bt1.347 billion. It’s apparent that the growth had been steady since 2009 to 2013 or for 5 years. The ratio of liabilities to shareholders’ equity in 2013 was at 0.50 percent, a drop from 0.60 percent in 2012. Dividend payment in the past 5 years, 2009-2013 grew steadily. This year the assembly would be asked to approve dividend payment at Bt0.80/share, considered a satisfactory result. The earnings per share were Bt1.50, dividend at Bt0.80/share.

The Managing Director also presented financial ratios in the past 5 years to the assembly, shown in the 2013 Annual Report.

Then the Chairman asked whether shareholders had any questions or wanted to share their opinions. No one asked a question.

The assembly acknowledged the Operating Results for the year 2013 as presented by the Managing Director.

Agenda 4: To consider and approve the Balance Sheets and Profit-Loss Statements for the period ending December 31, 2013

The Chairman presented to the assembly that the Balance Sheets and Profit-Loss Statements for the period ending December 31, 2013, had been prepared by the Company, audited by the auditor, Dharmaniti Auditing Co., Ltd., and approved by the Board of Directors. They would be presented to shareholders for the shareholders to approve. The Chairman then asked the Managing Director to present highlights to the assembly.

The Managing Director presented a summary of financial performance as of December 31, 2013 to the assembly as follows: The Company’s total assets stood at Bt2.025 billion – current assets of Bt296.80 million and non-current assets of Bt1.728 billion, while the total liabilities featured Bt678.31 million being current liabilities of Bt393.91 million and non- current liabilities of Bt284.40 million and shareholders’ equity of Bt650 million, paid up. Surplus from capital decrease was Bt7.11 million, surplus from distribution share buyback Bt105.08 million, retained earnings, allocated and set aside as statutory reserve fund Bt29.46 million, and surplus from asset appraisal Bt116.74 million, making the total shareholders’ equity to Bt1.347 billion. The total liabilities and shareholders’ equity stood at Bt2.025 billion.

In 2013, Sikarin registered a net profit of Bt148.68 million or profit per share of Bt1.50, compared with the net profit of Bt119.83 million or profit per share of Bt1.27 in 2012, thus featuring an increase of Bt28.85 mill or 24.07 percent.

In 2013, the revenue from medical services was Bt1.65 billion, compared with Bt1.526 billion in 2012, an increase of Bt124.87 million or 8.18 percent. It was because of the expansion of the service areas and increase in the number of medical personnel to enhance medical capabilities. Costs of medical services rose by Bt74.54 million or 7.03 percent compared with the figures in 2012.

Sikarin made increased earnings from food and drink sales by Bt7.67 million or 28.12 percent, compared with the figures in 2012 while the costs of foods and drinks rose by Bt2.70 million or 15.30 percent.

Then the Chairman asked whether shareholders had any questions about the Balance Sheets and Profit-Loss Statements as of December 31, 2013.

As nobody asked any questions, the Chairman asked to assembly to approve the Balance Sheets and Profit-Loss Statements for the period ending December 31, 2013.

The assembly unanimously resolved to approve the Balance Sheets and Profit-Loss Statements for the period ending December 31, 2013, earlier approved by the auditor as follows:

Shareholders No. of Shares (Votes) Percentage Approve, 74,136,812 100.0000 Disapprove, 0 0.0000 Abstain, 0 0.0000 Total 222 voters 74,136,812 100.0000

Notes: Three additional shareholders carrying 21,200 shares joined the meeting.

Agenda 5: To consider annual profit allocation and dividend payment

The Chairman asked the Managing Director to make a presentation to the assembly.

The Managing Director presented to the assembly that the Company was required to set aside not less than 5 percent of its net profit as statutory reserve fund or Bt7,433,953 in line with Section 25 of the Company’s Articles of Association and Sections 115 and116 of the Public Limited Company Act of 1992. According to the Company’s dividend policy, dividend payment should not exceed 70 percent of its net profit and the Company’s net profit as of December 31, 2013. As the net profit was Bt148,679,056 the dividend should not exceed Bt104,075,339. The Company agreed to pay out dividend for the year 2013 at Bt0.80 per share.

The Board’s opinions: The Board felt appropriate to ask the assembly to approve the allocation of net profit as statutory reserve fund and dividend payment for the year 2013 at Bt0.80 per share and shareholders entitled to attend the AGM, cast votes and receive the dividend should be those on the record date of March 27, 2014 and the list of shareholders should be compiled in accordance with Section 225 of the Securities and Stock Exchange Act. The registry record was closed on March 28, 2014. The dividend was scheduled for payment on May 22, 2014.

The Chairman asked whether the assembly had any questions on profit allocation and dividend payment.

The Managing Director added and presented to the assembly that additional space for specialized examination rooms last year, registration space for clients’ better conveniences had paid off – doctors from different specialized fields had joined Sikarin as earlier presented to the assembly. Last year, a new section was created to take care of foreign clients, and another section to facilitate investors as well as developed a customer database to cope with rising clients today and in the future.

As nobody raised a question, the Chairman asked the assembly to approve the annual profit allocation and dividend payment.

The assembly resolved to approve the annual profit allocation and dividend payment with the following details: 1. Approve the statutory reserve fund of Bt7,433,953 from the net profit. 2. Approve the dividend for 2013 at Bt0.80 per share. Shareholders entitled to dividend are those on the record date of March 27, 2014 and the list of shareholders should be compiled in accordance with Section 225 of the Securities and Stock Exchange Act. The registry record was closed on March 28, 2014. The dividend was scheduled for payment on May 22, 2014. The unanimous approvals were made with the following votes:

Shareholders No. of Shares (Votes) Percentage Approve, 74,136,812 100.0000 Disapprove, 0 0.0000 Abstain, 0 0.0000 Total 222 voters 74,136,812 100.0000

Agenda 6: To consider and appoint the Company’s Auditor and determine audit fees for 2014

The Chairman asked the Chairman of the Audit Committee to make a presentation of that matter.

Mr. Pramuanchai Taweesedt, Chairman of the Audit Committee, presented to the assembly that having evaluated the auditor’s performance and independency, the Audit Committee felt appropriate for the assembly to reinstate Dharmaniti Auditing Co., Ltd. by Mr. Pot Asawasantichai, Registration No. 4891 or another certified public accountant in the audit firm as Sikarin’s auditor for 2014, and propose an audit fee of Bt950,000, the same rate as the previous year.

As no one raised a question, the Chairman asked the assembly to appoint an auditor and determine audit fees for 2014.

The assembly unanimously agreed to appoint Dharmaniti Auditing Co., Ltd., by Mr. Pot Asawasantichai, Registration No. 4891 or another certified public accountant in the audit firm as Sikarin’s auditor for 2014, and agreed with the audit fee of Bt950,000, an increase of Bt60,000 the same rate as the previous year:

Shareholders No. of Shares (Votes) Percentage Approve, 74,136,812 100.0000 Disapprove, 0 0.0000 Abstain, 0 0.0000 Total 222 voters 74,136,812 100.0000

Agenda 7: To elect Directors to replace those whose term expires

The Chairman informed to the assembly that according to Section 9 of the Company’s Articles of Association and Section 71 of the Public Limited Company Act, one third of the Directors would leave the Board by rotation at each Annual General Meeting. Outgoing Directors might be reinstated. The Board featured 15 Directors. Five Directors whose term expired this year included:

1. Dr. Wissanu Kreangam, Chairman, Board of Directors, 2. Mr. Krajang Jaruprukphan, Independent Director, 3. Mr. Seni Jittakasem, Independent Director & Compensation Committee Member, 4. Mr. Senee Krajangsri, Director & Executive Director, 5. Mr. Amornrit Kaosaiyanon, Independent Director & Audit CommitteeMember.

The Recruitment Committee earlier nominated those five persons to the Board of Directors and hereby proposed the same list to shareholders to consider appointment of the following persons: 1. Dr. Wissanu Kreangam, Chairman, Board of Directors, 2. Mr. Krajang Jaruprukphan, Independent Director, 3. Mr. Seni Jittakasem, Independent Director & Compensation Committee Member, 4. Mr. Senee Krajangsri, Director & Executive Director, 5. Mr. Amornrit Kaosaiyanon, Independent Director & Audit Committee Member.

To be appropriate, the Chairman asked Pol. Lt. Gen. Jarax Saengtaweep, Vice Chairman & Executive Chairman, to chair the meeting on this agenda.

As no one raised a question, the Chairman asked the assembly to cast votes to elect Directors to replace those whose term had expired.

The assembly cast votes to unanimously re-elect the same 5 Directors, whose term had expired to take another office term as follows:

1. Dr. Wissanu Kreangam, Chairman, Board of Directors, Shareholders No. of Shares (Votes) Percentage Approve, 74,136,812 100.0000 Disapprove, 0 0.0000 Abstain, 0 0.0000 Total 222 voters 74,136,812 100.0000

2. Mr. Krajang Jaruprukphan, Independent Director, Shareholders No. of Shares (Votes) Percentage Approve, 74,136,812 100.0000 Disapprove, 0 0.0000 Abstain, 0 0.0000 Total 222 voters 74,136,812 100.0000

3. Mr. Seni Jittakasem, Independent Director & Compensation Committee Member, Shareholders No. of Shares (Votes) Percentage Approve, 74,136,812 100.0000 Disapprove, 0 0.0000 Abstain, 0 0.0000 Total 222 voters 74,136,812 100.0000

4. Mr. Senee Krajangsri, Director & Executive Director, Shareholders No. of Shares (Votes) Percentage Approve, 74,136,812 100.0000 Disapprove, 0 0.0000 Abstain, 0 0.0000 Total 222 voters 74,136,812 100.0000

5. Mr. Amornrit Kaosaiyanon, Independent Director & Audit Committee Member. Shareholders No. of Shares (Votes) Percentage Approve, 74,136,812 100.0000 Disapprove, 0 0.0000 Abstain, 0 0.0000 Total 222 voters 74,136,812 100.0000

Agenda 8: To consider remuneration for Directors

The Chairman presented to the assembly that the Compensation Committee, endorsed by the Board of Directors in line with Section 90 of the Public Limited Company Act of 1992, wished the assembly in the General Meeting to approve compensation, usually (1) by individual or (2) a lump sum which would be allocated to each committee, which Sikarin had opted for the second option all along and wished to continue with the same practice, and proposed that every committee as well as the Board of Directors and every sub-committee as position allowances, meeting allowances and returns would receive a total of Bt9,975,000 for the year 2014, equal to the past year.

Shareholder: A proposal. (Mr. Ekara Pratinipong) As the Chairman presented to us about additional activities and new buildings, isn’t it appropriate to increase the returns to Directors due to additional workload?

Managing Director: Clarifications. After discussing with the Board and Advisors, we agree to retain the rate of Bt9,975,000 as returns to the Board and committee members. If they have to handle additional workload, we may have to ask for the increase next year.

Shareholder: A question. (Mr. Tawisak Janaprakokko) As I attended the AGM elsewhere, this agenda was just for acknowledgement. But at Sikarin, two thirds approval was required, I wonder which’s correct based on which legal provisions?

Chairman: Clarifications. It’s from the same legal provisions. But this agenda couldn’t be for acknowledgement but required two thirds approval from shareholders or simple majority as in the case of election of an auditor, depending on each company’s choice.

As no one raised any other question, the Chairman asked the assembly to cast votes on the remuneration to Directors.

The assembly unanimously agreed with the compensation to every committee as well as the Board of Directors and every sub-committee as position allowances, meeting allowances and returns totaling Bt9,975,000, equal to the past year with more than two thirds votes of attendees as follows:

Shareholders No. of Shares (Votes) Percentage Approve, 74,136,812 100.0000 Disapprove, 0 0.0000 Abstain, 0 0.0000 Total 222 voters 74,136,812 100.0000

Agenda 9: Other businesses (if any)

The Chairman presented to the assembly that if anyone wanted to propose a matter for the assembly to consider, he/she required one third votes of shares sold to second. After asking the assembly to make a propose, no one made a proposal. However, the Chairman allowed shareholders to express their views or suggestions:

An IOD observer: A question. (Ms. Vilai Siripulkiatkul) Today most people are anti-corruption and IOD is seeking alliances to campaign against corruption. I have 4 questions about this matter: 1. What is Sikarin’s policy concerning anti-corruption? 2. What is Sikarin’s administration structure concerning anti- corruption? 3. Have you assessed risks concerning anti-corruption? 4. Are you interested in participating in that campaign? Chairman: The Chairman thanks the person who asks those questions, posed on behalf of all. They’re creative questions and society should answer those questions and they should be asked to every listed company. In fact, they’re questions at the national level as everyone is trying to do – national reform. The Board has 4 policies as follows: 1. Maximal conveniences to shareholders and patients who come to use services at the hospital:

This policy may not be directly related to the questions. We’ve set up an investor relations division to provide best conveniences to shareholders. Shareholders may not be clients or patients. That’s why we need a division to take care of shareholders and another division to take care of clients for their conveniences. As we’ve erected a new building and allocated proper medical service areas to meet the clients’ needs, Dr. Atirat Charoonsri, MD, Managing Director earlier said the space would be set aside for clients from the Middle East, another setting for Chinese clients or Asian clients. Facilities are not based on races but the number of foreign clients who may have problems with the language and religion. 2. Safety to patients and service receivers: To reduce risks to the hospital’s medical personnel as other hospitals are having problems with legal execution, not doctors suing patients but mostly patients suing doctors. With those risks, a lot of doctors have resigned from hospitals, closed their clinics and changed their career to aesthetic businesses to reduce risks. The number of medical students is dropping. But Sikarin PLC cannot lose heart and we’ve made sure to our doctors and nurses that they’ll be well protected if they strictly follow the hospital’s guidelines. Doctors may find it a bit inconvenient or patients feel who doctors are so fussy. They are all for their own benefits and to reduce risks. That’s why Sikarin PLC has set proper working procedures and they are quite acquainted with those procedures. Legal charges have subsequently dropped. 3. Profits returned to society: Though hospitals are business enterprises, we need to return something to society, not just a return to shareholders or as meeting allowances to Directors. Sikarin PLC has subsequently cooperated with the Cardiac Children Foundation of Thailandin providing early surgery to children suffering from congenital heart diseases. More than 80 children have been operated and lived like other normal children. We provide such services to Cambodian children as well because of (1) humanity and (2) we have a lot of patients from Cambodia and we’ve gained some profits from Cambodian patients. We should return some profits to the Cambodian society. A lot of children in Cambodia do not afford. 4. Anti-corruption policy: Sikarin PLC has had this policy for quite some time. Hospitals may be different from other businesses. Usually in other businesses, corruption can be seen in two aspects: 1) Internal corruption,

2) External corruption. Most other businesses usually have to deal with state authorities but Sikarin Hospital does not deal much with the state authorities as the hospital is not hired to construct a road or bridge and we don’t have to offer a bribe to those authorities. We have one obligation – paying taxes. Consequently, Sikarin has only risks of internal corruption. The executives have tried their best to cut down risks of internal corruption. We’ve come a long way. The JCI standards have required Sikarin to proceed as follows:

(1) Compliance with JCI standards and regulations: JCI inspects every process from the purchase of drugs, medical supplies, food for patients, building designs, patients’ wards, operation by medical doctors, nurses, patient information management, patient tending, etc. Only after passing all the standard requirements, JCI would provide accreditation and we can use the JCI logo. JCI is coming back to reassess those standards.

(2) Standard control and monitor: Once certified, we cannot take things easy but have to monitor to get prepared for reassessment. Sikarin PLC has employed those JCI standards and criteria to prevent corruption.

(3) Line of command: Payment approval is made by each supervisor. If the amount exceeds one’s authority, he/she has to pass it a higher supervisor. This is cross-checking process in addition of internal audit.

Furthermore, the Board has reviewed income-expense transactions, profit and loss statements, leaks, loopholes, if detected would be addressed in a Board meeting. The Board would follow up with prevention and solutions in the following meeting.

(4) Anti-corruption concerning drug purchase: Irregularities on drug purchase are considered serious. The hospital has set up a Drug Committee to review drug purchase. The stock has to be reviewed before each purchase order.

Sikarin PLC has focused on expense cut and income gain as a self-controlled measure to prevent leaks. A computer system is being set up by Mr. Suriyan Kojonroj, Corporate Secretary to enhance internal control efficiency.

In terms of administration structure in Question 2, we’ve put in place internal control, transparency, good corporate governance, proper internal audit and cross checks. No division has absolute authority to make decision by its own but it has to be cross-checked.

In terms of risk assessment in Question 3, Sikarin PLC has periodically assessed its risks as it has great concerns about monopoly which usually leads to corruption. Purchase is conducted through bidding process, except limited vendors. In such a case, we’ll choose a vendor offering the best to us. A good example is our new building. We believe the measures in place are quite sufficient. Some of our Directors who also serve in the Board in other companies have been approached by some private companies to sign a ratification or treaty to campaign against irregularities. As Sikarin PLC is a public health business, we’ve been approached by a few companies. We’re now considering with which company we’ll sign. In the meantime, we base our decision on the Lord Buddha’s 3 teachings: 1) Self-practice: By this way we don’t have to pay a bribe or tea money. 2) Instruction or coaching: Instructing or training our hospital personnel, doctors, nurses or financial staff about what’s risky and what’s been sued that they should avoid. 3) Best practice: Pick good examples and imitate them by signing with the Thai Chamber of Commerce, Medical Council of Thailand, Federation of Thai Industries. We’ll choose what is best to our Sikarin business and most beneficial to shareholders.

Shareholder: A proposal. (Ms. Pantip Poonpairoj) As the Managing Director mentions about alliances, who are mostly residents in the vicinity, I feel that Sikarin should expand its alliance base to schools as children today has high bargaining power. An example, Assumption College, SamutPrakan, which has some 3,000 students, has signed an accident insurance contract with a hospital. Everyday a school van will take students to the hospital. I suggest Sikarin approach that school and expand its alliance base to schools.

Managing Director: Thanks that shareholder’s advice and wishes to clarify that Sikarin has approached a few schools, Bangkok Pattana School, for example. For your information, Sikarin has the most child patients among hospitals in the vicinity. We have some 500 child patients on weekends. Our main patrons are schools. However, we’ll approach Assumption College, SamutPrakan and other schools in the vicinity.

Shareholder: I have been a shareholder at SKR for about a year and (Ms. Parita Manupratyanond) I believe the investment in SKR will yield high return to me and I wish to thank the Board and executives who have managed SKR and increased the value of SKR. I have a few questions: (1) How many minor and major shareholders are there? (2) Why do SKR stake stand still for quite some time and at other times, moving very fast? (3) What is the SKR future in the next two years?

Managing Director: Answers to those questions are in the 56-1 report and the Asst Managing Director is the best person to clarify.

Mr. Suriyan Kojonroj: I wish to let you know that Sikarin PLC has a total of (Asst Managing Director) 1,233 shareholders: 22 corporate shareholders, 7 foreign shareholders and 1,205 minor shareholders.

Managing Director: I wish to give you a full picture. A hospital business is your strong investment. I wish to thank you for holding our shares for about 10 years. That’s the main reason that supports our continuous growth. Your investment in SKR will turn into your offspring’s heritage. We’ll try to return to you in the form of dividend. A hospital business should focus on: (1) Safety: The Board has made clear a safety policy that will lead to business achievements. As earlier presented, hospital success factors are how to acquire capable doctors, nurses. (2) Hospital standards: Sikarin has been certified with JCI, the 2nd hospital in Thailand after Bamrungrad Hospital. It’s our pride. (3) How Sikarin will grow: As earlier presented, we can see that the surroundings are fast growing. In addition to the Thais, foreigners will come with the AEC.

Usually hospital shares are not much swinging but quite stable. The share swing is not caused by the hospital. A question of why the share price rose a lot this year which the management was monitoring as well and other people saw steady growth in the first 3 years out of the 6 years’ projection. This is the 5th year. We have steady growth. The level of share prices depends on the level of dividend. We have to focus on safety that will lead to business success, satisfactory dividend and shareholder satisfaction according the policy of the Chairman and Board. Trust and confidence rests with you all. However, share prices are quite reasonable compared with other hospitals. Hospitals focusing on safety and standard requirements will guarantee a success. With proper internal control, a steady growth is ensured. In terms of question 3, we will continue to grow steadily and our dividend will be more than what it’s this year. But we can’t guarantee the share prices, depending on your consideration what’s the proper prices.

Shareholder: I was surprised to see the Sikarin share prices. Before (Mr. Chatchai Vilairatanasuwan) holding shares, I have been a client here since 1993 and witnessed the hospital development. I do agree with the Managing Director’s presentation on the focus on hospital standards to control its personnel as I’m an executive in another private company. Compared with such hospitals as Smithivej, Bangkok Chain, Chularat, Ramkhamhaeng or Thai Nakharin, profit in percentage is lower than those hospitals. But if we follow those hospital standards, I believe we’ve come the right way. I wish the Board to look into expenses and in-house services which will subsequently improve the incentive, net income and net profit and help lower the P/E compared with dividend payment and with other hospitals.

In terms of services, as I’m a client and I feel that there are too many people at the counter that may cause communication confusion and defects as well as slow services. I used to ask for a medical certificate. Sometimes later I asked for it again. Eventually, I had to wait for about an hour to receive that certificate. I didn’t know why it took so much time. If such services are

improved, I believe we can retain our clients and other clients in the vicinity will come.

To finance a new building, will you please tell us where the source of funds is from either a loan or capital increase as it affects shareholders and dividend?

Managing Director: In terms of our services in the past 3 years, a computer system was introduced and nursed might have found it confused as we have introduced a policy that in the next 5 years, Sikarin will have to have least number of legal cases. Data has to be downloaded to the computer. I wish to thank doctors, nurses and other staff who have been cooperative. The data record has paid off as we have less legal cases. That has made Sikarin in the good average in the Stock Market. In terms of the medical certificate, the client might have asked for that certificate when the computer system broke down. However, I wish to thank you for your recommendations and we’ll improve accordingly.

In terms of the new building, it’s not quite big but sufficient to cope with business expansion. It’ll be completed in the next 18 months. The building is financed by a loan and cash in hands, without capital increase. We try to maintain the D/E Ratio not to exceed 0.50. The new building will be a bit larger than Building 2. There will be some more space for parking and diagnosis rooms. This is a very careful investment.

An IOD observer: Based on Mr. Chatchai Vilairatanasuwan’s question about (Ms. Vilai Siripulkiatkul) investment in loans, according to the Notes to Financial Statements No. 23, the agreement says no dividend payment shall be made until the principal has been paid back. My question is whether we’ll have dividend payment next year or not?

Managing Director: Such conditions are not in the agreement.

Miss Penruedee Jitlekha: adds that a condition for the loans is the D/E Ratio, not Director (Accounting and Finance) to exceed 1.5 times; DCSR (Debt Coverage Service Ratio) more than 1.5 times. And dividend not exceed 70 percent.

Shareholder: Please clarify. Today, the D/E Ratio is 0.50 times; Float (Mr. Chatchai Vilairatanasuwan) at 1 time; Equity at Bt1.3 billion. Maximal investment in the new building is Bt800 million. With a bit more than one time, Sikarin can easily pay dividend?

Shareholder: Please explain what Rattarin Hospital has been (Mr. Tawisak Janapramokko) performing.

Managing Director: Rattarin Hospital is situated in Bangpu. It has bright future. Formerly, it had some 38,000 social security members. After meeting with senior executives at different companies and factories in the vicinity and inviting them to see our facilities to witness the changes we’ve made, better services, computer systems, we believe the members will increase to 50,000-60,000 soon.

Rattarin Hospital is fast growing. The last BTS station will be just 700 meters away. Development will move towards Prakasa. Houses at the prices of Bt1-3 million Baht and twin houses will be built there. Rattarin will have a lot of opportunities. We’ll improve our wards, the front areas and install a CT Scan to better serve emergency patients.

Shareholder: What’s the income ratio between Rattarin and Sikarin? (Mr. Tawisak Janapramokko) What specialized areas is Rattarin well known?

Managing Director: The income ratio is 10.72% at Rattarin and 89.28% at Sikarin. Rattarin is specialized and well known in emergency services.

Shareholder: I wish to let you know that it’s my first attendance here. (MsVilai Tangsin) I wish to express my deepest appreciation to the Investor Relations Division. Her voice is nice and she has good relationship skills and follows up well. Secondly, Sikarin PLC has a chairman who is respected by everyone. When the Chairman says something, everyone listens attentively. We also have confident and visionary managing director, Dr. Atirat Charoonsri, MD. Thirdly, all the Directors on the stage are all males. I suggest we have some female Directors so that we may have more various prospects. Prospects from male and female directors may drive better growth to Sikarin. Hearing presentations on different matters, I believe I’ll buy

additional shares because of full confidence. I wish to thank every Director.

Managing Director: I wish to introduce Ms. Somsri Ruchutrakul, Director of Nursing Department. She’s the main person in the hospital’s operation. Ms. Somsri has strengthened investors’ confidence that though the market has nurse shortage, she will be able to recruit additional nurses to work in the new Building 3.

Shareholder: Questions. (Ms. Suratsawadi Lerterpongpat) (1) With the establishment of the Investors Relations Division, what criteria do you use to make a phone call to shareholders, for instance, a shareholder holding 10,000 shares or more? (2) Ramathibodi Hospital is being built here, will it affect Sikarin and Rattarin hospitals? (3) Do you have a record of the breakeven for the cost of construction of Buildings 1 & 2, compared to Building 3? How long is the breakeven point for Building 3? Will the loan payback be in 6 or more years? (4) As the share prices are swinging on the date of loan approval, it seems that the share prices today have reflected the prices as of the date of building construction completion. The prices will remain at this level for some time?

Prinda Wongsakul: In terms of Question 1, the Investors Relation Division (Director, Office of the Secretary) was setup not long before the AGM, its goal was to contact and invite as many shareholders as possible to the AGM. We didn’t have 10,000 share criteria. Some shareholders might have received our phone call and others might not. However, we’ve learned from defects and will do better next year.

Managing Director: In terms of Question 3, we’ll have a small building, 3 OPD floors and 8 IPD floors. Upon completion, our main income will come from Building 3 and the 3 OPD floors will be open immediately but only 4 IPD floors will be open. The other 4 floors will be for future expansion. The new building 3 will be good until 2017. We have to plan what to do next after 2017. Our plan is based on 15% normal growth. You can see how we’re well prepared.

In terms of Question 2, many people have learned about Ramathibodi Hospital and look at it in a positive way and good for Sikarin as Sikarin will be the center of agency with a helipad while Ramathibodi will start operation and medical instructors will work there from 2017. The new building at Sikarin will be completed before Ramathibodi opening. Hospitals close to an airport and having an alliance as a medical school are considered positive. If medical instructors wish to work at a private hospital, it should be Sikarin as it’s been certified with JCI. Ramathibodi also aims to be certified with JCI after its opening. Sikarin has prepared a schedule for medical instructors to visit patients.

In terms of Question 4, the SKR management wishes to explain to shareholders what they’ve done to reflect that operation result and wishes shareholders to analyze SKR operating result and dividend. If a hospital offers a good dividend, manages to control the D/E with proper operation standards, the share price will grow as it is. If they analyze that way, the price will be as it is. But if they believe something in the future, the prices may be different, not related to the operation. But the operation team will work their best to grow the business.

Chairman: The Chairman has introduced Mr. Sakchai Thanaboonchai, Vice Chairman and a Director of the Ramathibodi Foundation, responsible for fund raising for the construction of the Ramathibodi Foundation’s Medical Center, which will be located close to Sikarin Hospital. We deal with the Ramathibodi Foundation through Mr. Sakchai. Upon completion of the construction of the Ramathibodi Foundation’s Medical Center, we’ll have better cooperation. I believe with the close location of the Ramathibodi Foundation’s Medical Center, it’ll be good to Sikarin Hospital in terms of patient or personnel transfer and dependency on each other’s medical tools and equipment.

As no one raised any other question, the Chairman on behalf of Sikarin Public Co., Ltd. thanked the three vote-counting volunteers, hospital director, nurses, the executives and auditor as well as shareholders for their attendance and suggestions presented as well as their encouragement and support. The Chairman then declared the 2014 Annual General Meeting, No. 36 in 2014 adjourned.

The Meeting was adjourned at 11.30 a.m.

Signature …………………….Chairman of the Meeting (Prof. Dr. Wissanu Kreangam)

Signature ………………….... Minutes Taker (Mr. Suriyan Kojonroj)

(F 53-4)

Capital increase report form Sikarin Public Company Limited Date July 25, 2014

We, Sikarin Public Company Limited hereby report on the resolution of The Board of Directors Meeting no. 7/2014, held on July 25, 2014 from 13.00 to 14.00 hours, relating to a capital increase/share allotment as follows:

1. Capital increase: The board meeting passed a resolution approving the increase of the company’s registered paid up capital from THB 650 million to THB910 million by issuing 40,000,000ordinary shares with a par value of THB 6.50 each, totaling THB260million. Details of the each type of capital increase are as follows: Type of capital increase Type of share Number of Par value Total shares (THB/share) (THB million)

Specifying the purpose of Ordinaryshare 20,000,000 6.50 130,000,000 utilizing proceeds Preferred share - - - General Mandate Ordinaryshare 20,000,000 6.50 130,000,000 Preferred share - - -

2. Allotment of new shares: 2.1 If specifying the purpose of utilizing proceeds Allotted to Number of Ratio Sale price Subscription and Remark shares (old: new) (THB/share) payment period (shares) Exising shareholders 20,000,000 5 : 1 15.00 3-7 November 2557 - ...... General public - - - - ...... Other persons - - - - ...... (specify)...... To support the - - - - ...... conversion/ ...... exercising rights of a given instrument ...... (Specify) ......

2.1.1 Allotment of new shares 20,000,000 shares with a par value of THB 6.50 to existing shareholders. Rights offering at the ratio of 5 existing ordinary shares to 1 new share at the offering price of THB 15. The Record Date to determine the shareholders who are entitled to subscribe the newly issued shares on October 1, 2014. Also, October 2, 2014 shall be the book closing date on which the shareholders list as specified in section 225 of the Securities and Exchange Act shall be complied. The period of subscription the capital increase fromNovember 3, 2014 until November 7, 2014. 2.1.2 In case any newly issued ordinary shares remaining unsubscribed from the right offering, Board of director or person who has been authorized by the board of director must allocate newly issued ordinary shares remaining by excess right to existing shareholder’s need or an oversubscribed request by the same ratio proportion until newly issued ordinary share will be complete allocated. Allotment need to focus on newly issued ordinary share remaining and oversubscribed request. There for, the board of director or an authorized person by the board of director has right to settle newly issued policy and conditions. 2.1.3In case a share fraction, a shareholder allocated with a fraction of a share or less than one share, that fraction shall be deleted. 2.2General Mandate Allotted to Type of Number of Percentage Remark shares shares of paid-up (Shares) capital1/ Exising shareholders Ordinaryshare 15,000,000 15 % ...... Preferred share - - ...... To supporting the exercise of transferable subscription right

- - ...... General public Ordinaryshare - - ...... Preferred share - - ...... Specific persons Ordinaryshare 5,000,000 5 % ...... Preferred share - - ...... 1/Percentage of paid-up capital on the date that the Board of Directors resolves to increase capital under a general mandate. 3. Schedule for a shareholders’ meeting to approve the capital increase/allotment The Extraordinary meeting of shareholders no. 1/2014 held on September 11, 2014 on 9.00 hoursat the Meeting Room 2nd Floor, Building 1, Sikarin Hospital, No. 4/29, Moo 10, Srinakarin Road, Bang Na District, Bang Na Sub - district, Bangkok. The share register will be closed to share transfers in order to determine the right to attend this meeting from...... -...... until the meeting has been duly convened. The share register will be recorded for sharetransfer in order to determine the right to attend this meeting onAugust 14, 2014. Also, August 15, 2014 (one business

day after the recording date) will be the book-closing date on which the shareholder list as specified in section 225 of the Security Act shall be complied.

4. Approval of the capital increase/share allotment by relevant governmental agency and conditions thereto (if any) 4.1 The Company will register the capital increase with the Commercial Business Development Department, Ministry of Commerce. 4.2 The Company will apply for approvals from the Stock Exchange of Thailand for listing of new ordinary shares. 5. Objectives of the capital increase and plans for utilizing proceeds received from the capital increase. 5.1 Debt Settlement to financial institution 5.2 Set aside for the construction of multipurpose building 5.3 Set as working capital 5.4 Set aside for maintenance and development of additional service facilities in the future 6. Benefits which the Company will receive from the capital increase/share allotment: 6.1 Increase competitiveness and expanding business operations 6.2 To support the growth of the business 6.3 To enhance liquidity and working capital cash flow to execute its business 7. Benefits which shareholders will receive from the capital increase/share allotment: 7.1 Dividend policynot more than 70% of net profit each year 7.2 The shareholders who subscribe the newly issued shares will be entitled to receive dividend from the operating results for the year 2014 onwards 7.3 Others: -None - 8. Other details necessary for shareholders to approve the capital increase/share allotment: In case of capital increase as general mandate, at each share allocation, the Board of Directors shall disclose additional information according to the criteria for shareholders’ benefits. Schedule of action if the board of directors passes a resolution approving the capital increase or allotment of new shares: No. Procedures of the capital increase Date/Month/Year 1 The meeting of the Board of Directors 25 July 2014 2 Record Date to determine the shareholders right to attend the Extraordinary meeting 14 August 2014 no. 1/2014 3 Closing date of the register of shareholders to attend the meeting 15 August 2014 4 The Extraordinary meeting of shareholders no. 1/2014 11 September 2014 5 Record Date to determine the shareholders who are entitled to subscribe the newly 1 October 2014 issued shares 6 Closing date to collect the names of shareholders entitled to subscribe the newly 2 October 2014 issue shared 7 The period of subscription the capital increaseand payment 3 – 7 November 2014

The Company hereby certifies that the information contained in this report form is true and complete in all respects.

Sincerely Yours,

(Pol. Lt. Gen. Jarax Sangtaweep) Vice Chairman & Chief Executive Officer

General Information

Name of Company: Sikarin Public Company Limited Type of Business: Private Hospital Head Office Address: 4/29 Moo 10, Srinakarin Road, Bang Na Sub-district, Bang Na District, Bangkok 10260 Registration Number: PCL 0107528000018 Telephone: 1728, (66)2-366-9900 Fax: (66)2-366-9942 Website: http://www.sikarin.com E-mail: [email protected]

Products and Services Sikarin Public Company Limited operates two private hospitals which are Sikarin Hospital and Rattarin Hospital. Both hospitals have master in all fields is possible to say that Sikarin Hospital provide 24 hours of service where provide a service in both outpatient (OPD) and Inpatient (IPD). Medical Services at Sikarin Hospital Sikarin Hospital: situated at No. 4/29, Moo 10, Srinakarin Road, Bang Na Sub-district, Bang Na District, Bangkok, on a plot of land of 11 Rai 81 Square Wah, Officially inaugurated on December 16, 1993. There are 3 buildings, 235 beds for inpatients and with capability to handle an average of 2,800 outpatients per day where service area is totally 23,980 square meters. • Building 1 houses Sub Specialty Center, General Medicine, General Surgery, Orthopedic Center, Children Center, Dental Center and Sikarin Aesthetic Center. Including 3 Midnight Clinics which are Internal Medicine Clinic, Surgical Clinic and Children Center. • Sikarin Building 2 houses Specialized Women’s Health Center, Health Center, Eye Center and Ear, Throat, Nose Center. • Social Welfare Building provides a service for welfare outpatient in the service area of 380 square meters.

1. All OPD Room - Sub Specialty Center - Dermatology - Orthopedic Center - E.N.T Department - General Surgery - Department of Physical Therapy - Obstetrics – Gynecology - Nephrology - Children Center - Hydrotherapy - Dental Clinic Center - Emergency and Trauma Center - Eye Center 2. Dental Clinic rooms 3.Artificial Kidney Service rooms 4. Intensive care unit And Surgery rooms 5.Number of beds

Rattrin Hospital: situated at No. 999/23-29, Sukhumvit Road, Bangpu Mai Sub-district, Muang Districe, Samut Prakan Provionce on plot of land of 1 Rai and 46 Square Wah, Officially inaugurated on January 1, 1993, with 100 beds for inpatients and with capability to handle an average of 7000 outpatients per day.

Rattrin Hospital provides full time doctor covered in all medical fields such as, Internal Medicine Clinic, Surgical Clinic and Children Center Internal Branch Other Medical Department.

1.Out- patient Department Orthopedic Center Internal Medicine Obstetrics - Gynecology General Surgery Eye Center Children Center E.N.T Department Dermatology Emergency and Trauma Center Department of Physical Therapy 2. Intensive Care Unit 3. Number of beds 4. Surgery rooms

Service areas include 9 outpatient diagnosis and emergency rooms, 2 surgery rooms and 2 recovery rooms, 5 intensive care beds. As for quality management, Rattarin Hospital has been accredited with the ISO 9001 and HA Level 2.

Assets of the Company and its subsidiaries

Company Business Assets, As At March 31, 2014 March 31, 2014 December 31, 2013 Consolidated Consolidated Consolidated Financial Consolidated Financial Statements Statements Property, plant and equipment-net 1,614,117,440 1,614,117,440 1,575,141,216 1,575,141,216 Intangible assets-net 22,617,156 22,617,156 24,163,053 24,163,053 Leasehold right-net 48,317,271 48,317,271 49,233,156 49,233,156 Total value-net 1,685,051,867 1,685,051,867 1,648,537,425 1,648,537,425

3. List of executives and major shareholders The Board of Directors The Board of Directors of the Company as at August 15, 2014 List of Directors Position Dr.Wissanu Krea-ngam Chairman, Pol.Lt.Gen. Jarax Sangtaweep Chairman of the Executive Committee, Pol.Lt.Gen. Jarax Sangtaweep Vice Chairman, Mr. Sakchai Tanaboonchai Vice Chairman, Mr. Sanya Sarayudh Vice Chairman, Dr. Atirat Charoonsri Managing Director, Mr. Jarun Wiwatjesadawut Director, Mr. Senee Krajangsri Director, Mr. Raj Tanta-Nanta Director, Mr. Sucheep Boonveera Director, Mr. Kitipan Sasanavin Director, Dr. Wissanu Krea-ngam Independent Director, Mr. Krajang Jaruprukphan Independent Director, Mr. Sakchai Tanaboonchai Independent Director, Mr. Seni Jittakasem Independent Director, Mr. Pramuanchai Taweesedt Independent Director, Mr. Amornrit Kaosaiyanon Independent Director, Mr. Kasidit Ajanant Independent Director, Mr. Pramuanchai Taweesedt Chairman of the Audit Committee, Mr. Amornrit Kaosaiyanon Chairman of the Audit Committee, Mr. Kasidit Ajanant Chairman of the Audit Committee.

Management The Company’s management as at August 15, 2014 List of Management Position 1. Dr. Atirat Charoonsri Director & Managing Director, 2.Mr. Suriyan Kojonroj Assistant Managing Director & Chief Operating Officer, 3.Mr. Surasuk Suttamas Chief Executive Officer, 4. Mr. Senee Krajangsri Chief Financial Officer.

Note: "Management" in this section has the meanings given by the Capital Market Supervisory Board. This means the President Four executive positions, first from the President down. And those who hold positions equivalent to those held management positions at the four ranking.

Major shareholder structure A list of major shareholder structure Top 10, As at August 7, 2014

No. Shareholders No. of Shares Percentage

1. Charoonsri Group 21,677,530 21.68% Mr. Atirat Charoonsri 5,795,380 5.80% Mrs. Skaorat Charoonsri 3,729,800 3.73% Miss Sasinapa Charoonsri 3,654,500 3.65% Miss Natnapang Charoonsri 3,644,500 3.64% Mr. Teerapot Charoonsri 3,080,550 3.08% Mr. Nattawat Charoonsri 650,000 0.65% Mrs. Tritaporn Charoonsri 622,800 0.62% Miss Piengnapa Charoonsri 500,000 0.50% 2. Vibhavadi medical center public company limited 9,800,000 9.80% 3. Miss Malinee Boonrak 4,660,000 4.66% 4. Mahatthanarak Group 4,636,300 4.64% Miss Ninnate Mahatthanarak 4,229,400 4..23% Mrs. Nongyao Mahatthanarak 406,900 0.41% 5. Mr. Noppadon Khemayotin 4,500,000 4.50% 6. Mrs. Anchalee Pinrat 4,400,000 4.40% 7. MR. TENG, MING-TA 3,956,400 3.96% 8. Mr. Viroj Mutthakarn 3,500,000 3.50% 9. Mr. Sinchai Nisakronsit 3,401,000 3.40% 10 Sangsnit Group 2,090,600 2.09% Mr. Ravaron Sangsnit 2,030,600 2.03% Mr. Supoj Sangsnit 60,000 0.08%

4. Dividend Increase and in the past 3 years. (1) History recapitalization of the company in the past 3 years. - No -

(2) Dividends Company's policy no pay exceed more than 70 percent Net income each year. Pays dividends for the retroact 3 years (years 2011-2013) Payout Year Dividend for the performance Dividend / Months Dividend Share 2013 January,2012 - December ,2012 0.75 May 23, 2013 Bath/Share 2012 January,2011 - December ,2011 0.60 May 24, 2012 Bath/Share 2011 January,2010 - December ,2010 0.50 May 20, 2011 Bath/Share

5. Information subsidiary and associates March 31, 2014. Sikarin Public Company Limited had two hospitals under operated which are Sikarin Hospital, 235 beds and Rattarin Hospital, 100 beds. In addition, The Company has investments in 1 subsidiary, 2 associated companies and 1 other company are as follow:

SIKARIN Company (Public) • SIKARIN Hospital • RATTARIN Hospital

Sikarin Public Company Sikarin Hatyai Hospital Kanchanaburihealthcare Limited ( 99.99% ) Company Limited Hospital Company ( 11.77% ) Limited ( 6.67% )

Company Name Business Share All Par Shear the % Securities Value Company Shareholders

1.Sikarin Public Company Limited Rental Space 50,000 100 49,996 99.99% Common Office Location Management Bath Stock Programs and 976 Lasalle Road area Bang Na Sub-district, Bang Na District, Bangkok 10260

2.Sikarin Hatyai Hospital 400 Beds 6,500,000 10 3,120,000 11.77% Common Company Limited Bath Stock Office Location

169 Niphat songkor 1 Hatyai, Hatyai Songkhla 3. Kanchanaburihealthcare Hospital 100 Beds 10,562,720 10 1,000,000 6.67% Common Company Limited Bath Stock Office Location

111 Moo,5 Tarmakharm Amphoe muang Kanchanaburi, Kanchanaburi

Proxy Form A (a general and easy form) Attachment to the Announcement of Business Development Department on Regulation on Proxy Form (No. 5) 2007 ______Written at ______Date ______(1) I ______Nationality ______Residing at No. ______Road ______Sub-district ______District ______Province ______Postal Code ______(2) Being a shareholder of Sikarin Public Company Limited holding a total of ______shares, with voting right of ______shares thus: Common shares ______shares, with voting right of ______shares, Preferential shares____ shares, with voting right of ______shares, (3) I authorize • ______age _____ years, Residing at No. ______Road ______Sub-district ______District ______Province ______Postal Code ______or • ______age _____ years, Residing at No. ______Road ______Sub-district ______District ______Province ______Postal Code ______or • ______age _____ years, Residing at No. ______Road ______Sub-district ______District ______Province ______Postal Code ______Any one of them to be my Proxy in the Meeting and vote on my behalf in the 1Extraordinary General Meeting of Shareholders on Thursday, September11, 2014 at 9.00 a.m. at the Meeting Room, Building 1, 2nd Floor, Sikarin Hospital, No. 4/29, Srinakarin Road, Bang Na Sub- district, Bang Na District, Bangkok, or as postponed to another date, time and place.

Any action which the representative has done in the Meeting shall be deemed done by me in all respect. Signature ______Appointer ( )

Signature ______Appointee ( )

Signature ______Witness ( )

Signature ______Witness ( ) Note: The shareholder who appoints proxies shall appoint only one proxy to attend the Meeting and vote and cannot sub-divide the number of shares to various proxies to separate the voting.

Proxy Form B (a form with specific unchangeable details authorized) Attachment to the Announcement of Business Development Department on Regulation on Proxy Form (No. 5) 2007 ______

Written at ______Date ______(1) I ______Nationality ______Residing at No. ______Road ______Sub-district ______District ______Province ______Postal Code ______(2) Being a shareholder of Sikarin Public Company Limited holding a total of ______shares, with voting right of ______shares thus: Common shares ______shares, with voting right of ______shares, Preferential shares____ shares, with voting right of ______shares, (3) I authorize • ______age _____ years, Residing at No. ______Road ______Sub-district ______District ______Province ______Postal Code ______or • ______age _____ years, Residing at No. ______Road ______Sub-district ______District ______Province ______Postal Code ______or • ______age _____ years, Residing at No. ______Road ______Sub-district ______District ______Province ______Postal Code ______Any one of them to be my Proxy in the Meeting and vote on my behalf in the 1Extraordinary General Meeting of Shareholders on Thursday, September11, 2014 at 9.00 a.m. at the Meeting Room, Building 1, 2nd Floor, Sikarin Hospital, No. 4/29, Srinakarin Road, Bang Na Sub- district, Bang Na District, Bangkok, or as postponed to another date, time and place.

(4) I authorize the proxy to vote on my behalf in this Meeting as follow:  Agenda 1 Matters which the Chairman informs the Meeting for Acknowledgement, (a) The proxy is authorized to consider and vote on my behalf in all matters which he deems appropriate (b) The proxy is authorized to vote on my behalf thus:  agree  disagree  abstain

 Agenda 2 ToConsider and Approve the Minutes of the 36 Ordinary General Shareholders’ Meeting,  (a) The proxy is authorized to consider and vote on my behalf in all matters which he deems appropriate  (b) The proxy is authorized to vote on my behalf thus:  agree  disagree  abstain

 Agenda 3 To Considerto Change the Condition of Allotment of New Shares,  (a) The proxy is authorized to consider and vote on my behalf in all matters which he deems appropriate  (b) The proxy is authorized to vote on my behalf thus:  agree  disagree  abstain  Agenda 4 Others (if any)  (a) The proxy is authorized to consider and vote on my behalf in all matters which he deems appropriate  (b) The proxy is authorized to vote on my behalf thus:  agree  disagree  abstain

(5) The voting of the proxy in any Agenda which is not according to the statement in this Proxy, shall be considered as incorrect and shall not be my voting as a shareholder (6) In the cases which I do not specify my intent to vote in any Agenda or state unclearly, or in the case which the Meeting considers or approve any matter other than stated above, inclusive of amendment or addition certain facts, the proxy is authorized to consider and vote on my behalf as he deems appropriate.

Any action which the proxy has done in the Meeting shall be deemed done by me in all respects.

Signature ______Appointer ( )

Signature ______Appointee ( )

Signature ______Witness ( )

Note: 1. The shareholder who appoints proxies shall appoint only one proxy to attend the Meeting and vote and cannot sub-divide the number of shares to various proxies to separate the voting. 2. In the Agenda for election of Directors, voting can be done for the whole Board or by individual directors. 3. In the case in which there are more agendas than stated above, the Appointer may state additions to the Power of Attorney Form B as attached.

Attachment to the proxy Form B

Assigning a proxy as a shareholder of Sikarin Public Company Limited

In the 1Extraordinary General Meeting of Shareholders held on Thursday, September11, 2014 at 9.00 a.m. at the Meeting room, Building 1, 2nd Floor, Sikarin Hospital, No. 4/29, Srinakarin Road, Bang Na Sub-district, Bang Na District, Bangkok, or as postpone to other date, time and place

 Agenda __ Subject ______ (a) The proxy is authorized to consider and vote on my behalf in all matters which he deems appropriate (b) The proxy is authorized to vote on my behalf thus:  agree……votes  disagree…….votes abstain……votes

 Agenda __ Subject ______ (a) The proxy is authorized to consider and vote on my behalf in all matters which he deems appropriate  (b) The proxy is authorized to vote on my behalf thus:  agree……votes  disagree…….votes abstain……votes

 Agenda __ Subject ______ (a) The proxy is authorized to consider and vote on my behalf in all matters which he deems appropriate  (b) The proxy is authorized to vote on my behalf thus:  agree……votes disagree…….votes abstain……votes

Power of Attorney Form C (a form with specific for foreign shareholders and appointing a Custodian in Thailand as a depositor and share keeper)

Attachment to the Announcement of Business Development Department on Regulation on Proxy Form (No. 5) 2007 ______

Written at ______Date ______(1) I ______Nationality ______Residing at No. ______Road ______Sub-district ______District ______Province ______Postal Code ______Being a shareholder of Sikarin Public Company Limited Holding a total of ______shares, with voting right of ______shares thus: Common shares ______shares, with voting right of ______shares, Preferential shares_____ shares, with voting right of ______shares, (2) I authorize (1)______age _____ years, Residing at No. ______Road ______Sub-district ______District ______Province ______Postal Code ______or (2) ______age _____ years, Residing at No. ______Road ______Sub-district ______District ______Province ______Postal Code ______or (3) ______age _____ years, Residing at No. ______Road ______Sub-district ______District ______Province ______Postal Code ______Any one of them to be my proxy in the Meeting and vote on my behalf in the 1Extraordinary General Meeting of Shareholders held on Thursday, September11, 2014 at 9.00 a.m. at the Meeting Room, Building 1, 2nd Floor, Sikarin Hospital, No. 4/29, Srinakarin Road, Bang Na Sub-district, Bang Na District, Bangkok, or as postponed to another date, time and place.

(3) I authorize the proxy to vote on my behalf in this Meeting as follow:  representing all the shares I hold and having voting right  representing a part of the shares: Common shares………………shares and right to votes……………………..votes Preferential shares………………shares and right to votes……………………..votes

(4) I authorize the proxy to vote on my behalf in this Meeting as follow:  Agenda 1 Matters which the Chairman informs the Meeting for acknowledgement,  (a) The proxy is authorized to consider and vote on my behalf in all matters which he deems appropriate  (b) The proxy is authorized to vote on my behalf thus: 39

 agree……votes disagree…….votes abstain…votes

 Agenda 2 To consider and approve the Minutes of the 36 Ordinary General Shareholders’ Meeting, (a) The proxy is authorized to consider and vote on my behalf in all matters which he deems appropriate (b) The proxy is authorized to vote on my behalf thus:  agree……votes  disagree…….votes  abstain…votes

 Agenda 4 Others (if any)  (a) The proxy is authorized to consider and vote on my behalf in all matters which he deems appropriate (b) The proxy is authorized to vote on my behalf thus:  agree……votes  disagree…….votes abstain…votes

(5)The voting of the proxy in any Agenda which is not according to the statement in this Power of Attorney, shall be considered as incorrect and shall not be my voting as a shareholder

(6)In the cases which I do not specify my intent to vote in any Agenda or state unclearly, or in the case which the assembly considers or approves any matter other than stated above, inclusive of amendment or addition of certain facts, the proxy is authorized to consider and vote on my behalf as he deems appropriate.

Any action which the proxy has done in the Meeting shall be deemed done by me in all respects.

Signature ______Appointer ( )

Signature ______Appointee ( )

Signature ______Witness ( )

Note: 1. This proxy Form C is specifically for shareholders in the registrar of foreign shareholders and appointing a Custodian in Thailand as a depositor and share keeper only. 2. The evidence necessary to accompany the Proxy: (1) The Proxy to a Custodian to sign in the Proxy on his behalf. 3. The shareholder who appoints proxies shall appoint only one proxy to attend the Meeting and vote and cannot sub-divide the number of shares to various proxies to separate the voting. 4. In the Agenda for election of Directors, voting can be done for the whole Board or by individual Directors. 5. In the case in which there are more agendas than stated above, the Appointer may state additions to the Proxy Form C as attached.

Attachment to the proxy Form C

Assigning a proxy as a shareholder of Sikarin Public Company Limited

 Agenda __ Subject ______ (a) The proxy is authorized to consider and vote on my behalf in all matters which he deems appropriate  (b) The proxy is authorized to vote on my behalf thus:  agree……votes  disagree…….votes  abstain……votes

 Agenda __ Subject ______ (a) The proxy is authorized to consider and vote on my behalf in all matters which he deems appropriate  (b) The proxy is authorized to vote on my behalf thus: agree……votes  disagree…….votes  abstain……votes

 Agenda __ Subject ______ (a) The proxy is authorized to consider and vote on my behalf in all matters which he deems appropriate  (b) The proxy is authorized to vote on my behalf thus:  agree……votes  disagree…….votes  abstain……votes

Criteria, methods and regulations on those concerning

The Extraordinary General Meeting of Shareholders

1. In the case of attending the Meeting in person • The shareholder, being an ordinary person, Thai nationality, is required to show his/her ID card or Civil Servant ID Card. • The shareholder, being an ordinary person, foreign nationality, is required to show his/her foreign ID card or passport. • If there is any change of name and surname, evidence shall be shown.

2. In the case of a proxy • A stamp duty of Bt20 shall be affixed on the proxy form, • The proxy and identification to join the Meeting shall be shown before the Meeting begins. • If the appointer is an ordinary person, Thai nationality, a copy of his/her ID card or Civil Servant ID Card, certified true and correct, shall be submitted. • If the appointer is an ordinary person, foreign nationality, a copy of his/her foreign ID card or passport, certified true and correct,shall be submitted. • If the appointer is a juristic entity, Thai nationality, a certificate of the company, issued by the Commerce Ministry not over 1 year old, and a copy of the ID card or Civil Servant ID Card,certified true and correct, of the authorized Directors shall be submitted. • If the appointer is a juristic entity, foreign nationality, the authorized person shall affix his/her signature together with the company’s stamp on the proxy form before a notary public, before getting the Thai Embassy or the Thai Consulate certify the notary public. • In case of fingerprints in place of signatures, at least two witnesses are required to certify. • If a shareholder wishes to appoint a proxy who is an Audit Committee member and also an independent Director to cast votes for him/her, you may appoint one of the following Directors: - Mr. Pramuanchai Taweesedt, No. 333/343, Moo 6, Thung Song Hong Sub-district, Lak Si District, Bangkok, - Mr. Amornrit Kaosaiyanon, No. 485, SoiOnnuch 46, SuanLuang Sub-district, SuanLuang District, Bangkok, - Mr. Kasadit Ajanant, No. 30/2 Soi Ramkamhaeng 21 (Nawasri), Wangthonglang Sub-district, Wangthonglang District, Bangkok. • In case of appointing an independent Director as his/her proxy, the proxy form completed with the signature and documents concerned shall be sent to the Corporate Secretariat prior to the date of the Meeting. 43

3. In case the shareholder is dead • The Estate Administrator shall attend the meeting on his/her behalf and shall present a Court Order appointing the Estate Administrator. • In case appointing another person to attend the meeting, the Court Order and ID card or Civil Servant ID Card shall be submitted.

4. In case the shareholder is a minor • His/her father or mother shall represent him/her by submitting a copy of the House Registration in which the minor’s name appears. • In case of appointing another person to attend the meeting, a copy of the House Registration in which the minor’s name appears, and ID card or Civil Servant ID Cardare required.

5. Registration • Registration begins before the Meeting, from 7.00 a.m. onwards. • In case of registration during the course of the meeting, that shareholder will receive a vote ballot only for the Agenda under discussion at the time of registration.

6. Regulations on the Shareholders Meeting 6.1 Meeting notification, • Section 12. The Board of Directors shall arrange for an Annual General Meeting of Shareholdersin 4 months from the end of the Company’s accounting cycle. - Other Shareholders’ Meetings shall be called Extraordinary General Meetings. • Section 15.To call a Shareholders’ meeting, the Board of Directors shall prepare a meeting notification stating the meeting venue, date, time, agendas and matters to be proposed in the meeting with sufficient details, clearly stating that they are for shareholders’ acknowledgement, approval or consideration as the case may be, as well as the Board’s opinions on those matters, and deliver it to shareholders and the Registrar at least 7 days before the date of the meeting. The notification for the meeting shall be advertised in a newspaper for at least 3 days before the date of the meeting. - The meeting venue shall be in the area where the Head Office of the Company is situated.

6.2 The quorum * Section 16. In a Shareholders’ Meeting, at least 25 shareholders and their proxies and carrying at least one third of the shares issued attend the meeting in order to form a quorum for the meeting.

- In case of a Shareholders’ Meeting in which it is found that after one hour after the notification time, the number of shareholders attending the meeting cannot form the quorum as prescribed, another meeting shall be called, and a 44

notification for the other meeting shall be sent to shareholders at least 7 days before the meeting date. In the latter meeting, at least 10 shareholders and their proxies attending the meeting can form a quorum for the meeting.

6.3 Voting * Section 10(1). A shareholder shall carry one vote per share. * Section 14. Shareholders shall have the right to attend the meeting and cast their votes in the Shareholders’ Meeting. He/she may appoint a proxy to attend the meeting and cast votes on his/her behalf. * Section 17. In a Shareholders’ Meeting, a resolution of the Shareholders’ Meeting shall be reached by the following votes: (1) In an ordinary case, the majority votes of the shareholders who attend the meeting and vote is considered a resolution. If votes cast on an issue are equal, the Chairperson in the meeting shall have another vote as the decisive vote. * Section 31 of the Public Limited Company Act says “The company may amend the Memorandum of Association or Articles of Association if shareholders in a meeting cast three fourths’ votes carried by shareholders attending the meeting and having the rights to vote.” To make an amendment to the Memorandum of Association or Articles of Association, the registered company shall proceed with the amendments in forty days from the date of shareholders’ resolution.

6.4 Capital increaseandAllotment of new shares * Section 136 of the Public Limited Company Act says The company may increase the amount of its registered capital by the issuance of new shares. The issuance of new shares under the first paragraph may be made after: 1. All the shares have been completely sold and paid-up in full, or, if the shares have not been completely sold, the remaining shares shall be the shares issued for the exercise of rights under convertible debentures or certificates representing rights to purchase shares 2. The shareholder meeting has passed a resolution by not less than three quarters of the total number of voices of the shareholders attending the meeting and having the right to vote; and 3. The said resolution has been submitted to the Registrar for the registration of a change in the registered capital within fourteen days of the date on which the meeting passes such resolution.

* Section 137 of the Public Limited Company Act saysThe new shares under Section 136 may be offered for sale in whole or in part and may be first offered for sale to the shareholders in proportion to the number of shares already held by each of them or may be offered for sale to the public or other persons either in whole or in part in accordance with the resolution of the shareholder meeting and Section 38 shall apply, mutatis mutandis.

6.5 In case no regulation is prescribed in the Articles of Association,

* Section 1. The Article of Association, if not specified otherwise, legal provisions in the Public Limited Company Act shall apply.

Independent Director’s Profile

Name : Mr. Pramuanchai Taweesedt Age : 58 years Current position in the company : Director and Chairman of the Audit Committee Recruitment criteria and procedures: Education : Master of Business Administration, Font Bonne College, USA, : Bachelor of Electrical Power, Faculty of Engineering, Chulalongkorn University, Relevant Training : VS Accounting Principles, Taxation Principles, the differences that look similar, : Accounting for Non-Accounting Aidit Committee, : Director Accreditation Program (DAP), Batch 56/2006, : Director Certification Program (DCP) Batch 119/2009, Position/Work Experiences : 2009 – the present Managing Director, Sri Uthong Co., Ltd., 2007 – 2008 Managing Director, STFE Co., Ltd., 2006 – 2012 Director, Thai-Finnish Chamber of Commerce, 2005 – the present Director, Sikarin Public Co., Ltd., 1993 – 2008 Deputy Managing Director, Sri Uthong Co., Ltd., 1991 – 1993 Project Engineer, Kuether & Associates, Inc. USA/Engineering Consultant,

Profile related to Sikarin Public Co., Ltd. : Position Director : Director : Director of the Audit Committee Management Committee : None Number of years holding a director’s position in SKR : 8 years (since 2005) SKR Shareholding : None Meeting attendance in 2013 : Board of Directors Meeting 12/12 Legal Dispute : No legal dispute during the past 5 years

Position in other Company Position in other Listed Company - None - Position in other Organization (Non-listed Company 1 Organization as follows: 1. Managing Director, Sri Uthong Co., Ltd., , Present directorship in other business with potential conflicts of interest - None - Relationship with management committee or major shareholders of SKR or its affiliates - None -

Nature of relationships with company/affiliated/associated companies or juristic persons with potential conflicts of interest in present - None -

Business relationships with company in such a way that may affect their independence - None -

Independent Director’s Profile

Name : Mr. Amornrit Kaosaiyanon Age : 64 years Current position in the company : Director and Director of the Audit Committee Recruitment criteria and procedures : The current Director, whose term has come to an end. The Board has considered their qualifications, knowledge, capability and experience and feels that they are qualified in line with the Public Limited Company Act and possess no prohibition qualifications from being appointed as a Director in accordance with the criteria of the Office of the Securities Exchange and Commission and other related government agencies. Education : Master’s Degree of Public Administration Program in Public and Private Management, National Institute of Development Administration, : Mini MBA, Faculty of Commerce and Accounting, Chulalongkorn University, : Bachelor’s Degree of Economics Program in Economics of Money and Banking, University of the Thai chamber of Commerce, Relevant Training : None Position/Work Experiences : 2009 – the present Director, Sikarin Public Co., Ltd., 1997 – 2009 Deputy Director, Kasikorn Bank (Zone Manager), 1981 – 1997 Branch Manager, Kasikorn Bank - Teparak Road - Sapanmai Donmuang - Pakchong - Pathumthani -Khlong Jun - Samutprakarn Profile related to Sikarin Public Co., Ltd. : Position Director : Director : Director of the Audit Committee Management Committee : None Number of years holding a director’s position in SKR : 4 years (since 2009) SKR Shareholding : None Meeting attendance in 2013 : Board of Directors Meeting 12/12 Legal Dispute : No legal dispute during the past 5 years

Position in other Company Position in other Listed Company - None - Position in other Organization (Non-listed Company - None - Present directorship in other business with potential conflicts of interest - None -

Relationship with management committee or major shareholders of SKR or its affiliates - None -

Nature of relationships with company/affiliated/associated companies or juristic persons with potential conflicts of interest in present - None -

Business relationships with company in such a way that may affect their independence - None -

Independent Director’s Profile

Name : Mr. Kasidit Ajanant Age : 33 years Current position in the company : Director and Director of the Audit Committee Recruitment criteria and procedures : Education : Master’s degree in Engineering, Stanford University, USA, Bachelor’s degree in Engineering, Brigham Young University, USA, Relevant Training : None Position/Work Experiences : 2012 – the present Director, Sikarin Public Co., Ltd., 2005 – 2009 Engineer, WSP Cantor Seinuk, New York, USA Profile related to Sikarin Public Co., Ltd. : Position Director : Director, Management Committee : None Number of years holding a director’s position in SKR : 1 year 7 months (since May 2012 - present) SKR Shareholding : None Meeting attendance in 2013 : Board of Directors Meeting 9/12 Legal Dispute : No legal dispute during the past 5 years Position in other Company

Position in other Listed Company - None - Position in other Organization (Non-listed Company) - None -

Present directorship in other business with potential conflicts of interest - None -

Relationship with management committee or major shareholders of SKR or its affiliates - None -

Nature of relationships with company/affiliated/associated companies or juristic persons with potential conflicts of interest in present - None - Business relationships with company in such a way that may affect their independence - None -